Positioning prostanoids of the D and J series in the immunopathogenic scheme

Immunology Letters

Volumn 102, Issue 2, 2006, Pages 121-131

  Herlong, J L ^a   Scott, T R ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

CRTH2; DP1; H PGDS; L PGDS; Prostaglandin D2; Prostaglandin J2

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ALBUMIN; ARACHIDONIC ACID; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 8; ISOPROSTANE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN G2; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; PROSTANOID; PROSTANOID RECEPTOR; PROTEIN DP 1 RECEPTOR; PROTEIN DP 2 RECEPTOR; PROTEIN HEMATOPOIETIC TYPE PROSTAGLANDIN SYNTHASE; PROTEIN HYDROPEROXIDASE; PROTEIN LIPOCALIN TYPE PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CELLULAR DISTRIBUTION; CYTOSOL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SPECIES COMPARISON; TISSUE DISTRIBUTION;

ANIMALS; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; ISOPROSTANES; MICE; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN;

EID: 30144441424     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.10.004     Document Type: Review

References (167)

1. 2 - anti-tumor and anti-viral activities and the mechanisms involved Eicosanoids 3 1990 189 199
2. S. Offenbacher, B.M. Odle, and T.E. Van Dyke The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss J Periodontal Res 21 1986 101 112
3. 2 synthases Biochem J 359 2001 507 516
4. 2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation Circ Res 71 1992 1305 1313
5. 2 in normal and asthmatic men N Engl J Med 311 1984 210 213
6. 2 in the hyperthermia of rats caused by bacterial lipopolysaccharide Proc Natl Acad Sci USA 79 1982 6093 6097
7. 2 and its analogues Br J Pharmacol 85 1985 367 375
8. I.P. Hall Second messengers, ion channels and pharmacology of airway smooth muscle Eur Respir J 15 2000 1120 1127
9. 2 induces sleep when microinjected into the preoptic area of conscious rats Biochem Biophys Res Commun 109 1982 576 582
10. 2 and sleep regulation Biochem Biophys Acta 1436 1999 606 615
11. 2 in sleep-wake regulation - recent progress and perspectives Neuroscientist 8 2002 12 15
12. N. Eguchi, T. Minami, N. Shirafuji, Y. Kanaoka, T. Tanaka, and A. Nagata Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice Proc Natl Acad Sci USA 96 1999 726 730
13. 2 as a mediator of allergic asthma Science 287 2000 2013 2017
14. Y. Urade, N. Fujimoto, M. Ujihara, and O. Hayaishi Biochemical and immunological characterization of rat spleen prostaglandin D synthetase J Biol Chem 262 1987 3820 3825
15. 2 Prostaglandins 35 1988 277 300
16. Y. Urade, M. Ujihara, Y. Horiguchi, K. Ikai, and O. Hayaishi Mast cells contain spleen-type prostaglandin D synthetase J Biol Chem 265 1990 371 375
17. Y. Urade, and O. Hayaishi Prostaglandin D synthase: structure and function Vitam Horm 58 2000 89 120
18. Y. Kanoka, and Y. Urade Hematopoietic prostaglandin D synthase Prostaglandins Leukot Essent Fatty Acids 69 2003 163 167
19. D.W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Clark, and D.A. Willoughby Inducible cyclooxygenase may have anti-inflammatory properties Nat Med 5 1999 698 701
20. 2 is an early anti-inflammatory signal in experimental colitis Am J Physiol Gastrointest Liver Physiol 279 2000 238 244
21. A. Ianaro, A. Ialentia, P. Maffia, B. Pisano, and M. Di Rosa Role of cyclopentanone prostaglandins in rat carrageenin pleurisy FEBS Lett 508 2001 61 66
22. Y. Urade, N. Fujimoto, and O. Hayaishi Purification and characterization of rat brain prostaglandin D synthetase J Biol Chem 260 1985 12410 12415
23. Y. Urade, and O. Hayaishi Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase Biochem Biophys Acta 1482 2000 259 271
24. E. Christ-Hazelhof, and D.H. Nugteren Purification and characterization of prostaglandin endoperoxide d-isomerase, a cytoplasmic, glutathione-requiring enzyme Biochem Biophys Acta 572 1979 43 51
25. Y. Urade, and N. Eguchi Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence Prostaglandins Other Lipid Mediat 68-69 2002 375 382
26. Y. Kanaoka, H. Ago, E. Inagaki, T. Nanayama, M. Miyano, and R. Kikuno Cloning and crystal structure of hematopoietic prostaglandin D synthase Cell 90 1997 1085 1095
27. Y. Kanaoka, H. Ago, E. Inagaki, T. Nanayama, M. Miyano, and R. Kikuno Cloning and crystal structure of hematopoietic prostaglandin D synthase Cell 96 1999 449
28. Y. Kanoka, K. Fujimori, R. Kikuno, Y. Sakaguchi, Y. Urade, and O. Hayaishi Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase Eur J Biochem 267 2000 3315 3322
29. 2 formation in rat mesangial cells Eur J Biochem 210 1992 169 176
30. 2 in human fibroblasts J Biol Chem 267 1992 23451 23454
31. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis Proc Natl Acad Sci USA 90 1993 4475 4479
32. 2 that mediates prostaglandin production in mast cells J Biol Chem 272 1997 13591 13596
33. 2 Prostaglandins Leukot Essent Fatty Acids 69 2003 87 97
34. W. Xie, J.G. Chipman, D.L. Robertson, R.L. Erikson, and D.L. Simmons Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc Natl Acad Sci USA 88 1991 2692 2696
35. M.K. O'Banion, V.D. Winn, and D.A. Young cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase Proc Natl Acad Sci USA 89 1992 4888 4892
36. T. Hla, and K. Neilson Human cyclooxygenase-2 cDNA Proc Natl Acad Sci USA 89 1992 7384 7388
37. B.S. Fletcher, D.A. Kujubu, D.M. Perrin, and H.R. Herschman Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase J Biol Chem 267 1992 4338 4344
38. S.T. Reddy, and H.R. Herschmann Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages J Biol Chem 269 1994 15473 15480
39. K.A. Pritchard, M.K. O'Banion, J.M. Miano, N. Vlasic, U.G. Bhatia, and D.A. Young Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo J Biol Chem 269 1994 8504 8509
40. D.L. Simmons, R.M. Botting, and T. Hla Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol Rev 56 2004 387 437
41. H.R. Herschman Prostaglandin synthase 2 Biochem Biophys Acta 1299 1996 125 140
42. Y. Urade, K. Watanabe, and O. Hayaishi Prostaglandin D, E, and F synthases J Lipid Mediat Cell Signal 12 1995 257 273
43. 2 J Biol Chem 258 1983 11713 11718
44. 2 metabolite generated during inflammatory processes J Biol Chem 277 2002 10459 10466
45. 2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase J Biol Chem 278 2003 28479 28489
46. Y. Urade, N. Fujimotot, T. Kaneko, A. Konishi, N. Mizuno, and O. Hayaishi Postnatal changes in the localization of prostaglandin D synthetase from neurons to oligodendrocytes in the rat brain J Biol Chem 262 1987 15132 15136
47. D.R. Flower The lipocalin protein family: structure and function Biochem J 318 1996 1 14
48. Y. Urade, K. Kitahama, H. Ohishi, T. Kaneko, N. Mizuno, and O. Hayaishi Dominate expression of mRNA for prostaglandin D synthetase in leptomeninges, choroids plexus, and oligodendrocytes of the adult rat brain Proc Natl Acad Sci USA 90 1993 9070 9074
49. Y. Tokugawa, I. Kunishige, Y. Kubota, K. Shimoya, T. Nobunaga, and T. Kimura Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma Biol Reprod 58 1998 600 607
50. R.L. Gerena, N. Eguchi, Y. Urade, and G.J. Killian Stage and region-specific localization of lipocalin type prostaglandin D synthase in the adult murine testis and epididymis J Adrol 21 2000 848 854
51. Y. Eguchi, N. Eguchi, H. Oda, K. Seiki, Y. Kijima, and Y. Matsu-ura Expression of lipocalin-type prostaglandin D synthase (β-trace) in human heart and its accumulation in the coronary circulation of angina patients Proc Natl Acad Sci USA 94 1997 14689 14694
52. 2 in spontaneous and augmented labor Life Sci 41 1987 1611 1614
53. N. Hirawa, Y. Uehara, T. Ikeda, T. Gomi, K. Hamano, and Y. Totsuka Urinary prostaglandin D synthase (β-trace) excretion increases in the early-stage of diabetes mellitus Nephron 87 2001 321 327
54. S. Grunewald, K. Huyben, J.G. de Jong, J.A. Smeitink, E. Rubio, and G.H. Boers Beta-trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain Biochim Biophys Acta 1455 1999 54 60
55. T. Tanaka, Y. Urade, H. Kimura, N. Eguchi, A. Nishikawa, and O. Hayaishi Lipocalin-type prostaglandin D synthase (β-trace) is a newly recognized type of retinoid transporter J Biol Chem 272 1997 15789 15795
56. C.T. Beuckmann, M. Aoyagi, I. Okazaki, T. Hiroike, H. Toh, and O. Hayaishi Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase Biochemistry 38 1999 8006 8013
57. M. Otsuki, H. Gao, K. Dahlman-Wright, C. Ohlsson, N. Eguchi, and Y. Urade Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor β Mol Endocrinol 17 2003 1844 1855
58. L.F. Garcia-Fernandez, Y. Urade, O. Hayaishi, J. Bernal, and A. Munoz Identification of a thyroid hormone response element in the promoter region of the rat lipocalin-type prostaglandin D synthase (β-trace) gene Brain Res Mol Brain Res 55 1998 321 330
59. L.F. Garcia-Fernandez, M.A. Iniguez, N. Eguchi, M. Fresno, Y. Urade, and A. Munoz Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells J Neurochem 75 2000 460 470
60. J.A. Mong, N. Devidze, D.E. Frail, L.T. O'Connor, M. Samuel, and E. Choleris Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: evidence from highdensity oligonucleotide arrays and in situ hybridization Proc Natl Acad Sci USA 100 2003 318 323
61. D. Sheehan, G. Meade, V.M. Foley, and C.A. Dowd Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily Biochem J 360 2001 1 16
62. J.D. Hayes, and L.I. McLellan Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defense against oxidative stress Free Radic Res 31 1999 273 300
63. P.G. Board, M. Coggan, G. Chelvanayagam, S. Easteal, L.S. Jermiin, and G.K. Schulte Identification, characterization, and crystal structure of the omega class glutathione transferases J Biol Chem 275 2000 24798 24806
64. E. Christ-Hazelhof, D.H. Nugteren, and D.A. Van Dorp Conversion of prostaglandin endoperoxides by glutathione S-transferases and serum albumins Biochem Biophys Acta 450 1976 450 461
65. 2 Arch Biochem Biophys 259 1987 548 557
66. 2 by various rat glutathione S-transferase isozymes Arch Biochem Biophys 264 1988 428 437
67. E. Pinzar, M. Miyano, Y. Kanaoka, Y. Urade, and O. Hayaishi Structural basis of hematopoietic prostaglandin D synthase activity elucidated by site-directed mutagenesis J Biol Chem 275 2000 31239 31244
68. T. Inoue, D. Irikura, N. Okasaki, S. Kinugasa, H. Matsumura, and N. Uodome Mechanism of metal activation of human hematopoietic prostaglandin D synthase Nat Struct Biol 10 2003 291 296
69. 2 synthase, a novel class sigma glutathione S-tranferase Biochem J 333 1998 317 325
70. Y. Kanoka, K. Fujimori, R. Kikuno, Y. Sakaguchi, Y. Urade, and O. Hayaishi Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase Eur J Biochem 267 2000 3315 3322
71. 2 generation in immature mouse mast cells J Biol Chem 270 1995 3239 3246
72. 2 by human helper T subsets J Immunol 164 2000 2277 2280
73. T. Suzuki, K. Watanabe, Y. Kanaoka, T. Sato, and O. Hayaishi Induction of hematopoietic prostaglandin D synthase in human megakaryoblastic cells by phorbol ester Biochem Biophys Res Commun 241 1997 288 293
74. I. Mahmud, N. Ueda, H. Yamaguchi, R. Yamashita, S. Yamamoto, and Y. Kanaoka Prostaglandin D synthase in human megakaryoblastic cells J Biol Chem 272 1997 28263 28266
75. 2 production is likely antigen-presenting cells, localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues J Immunol 143 1989 2982 2989
76. K. Fujimori, Y. Kanaoka, Y. Sakaguchi, and Y. Urade Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells J Biol Chem 275 2000 40511 40516
77. J.W. Voss, L. Wilson, and M.G. Rosenfold POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter Genes Dev 5 1991 1309 1320
78. J.O. Ebinu, D.A. Bottorff, E.Y. Chan, S.L. Stang, R.J. Dunn, and J.C. Stone RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs Science 280 1998 1082 1086
79. Y. Yang, L. Li, G.W. Wong, S.A. Krilis, M.S. Madhusudhan, and A. Sali RasGRP4, a new mast cell-restricted ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs J Biol Chem 277 2002 25756 25774
80. 2 in human and rat mast cell lines J Biol Chem 278 2003 4725 4729
81. 2 in mouse mast cells J Biol Chem 279 2004 48923 48929
82. T.J. Hemesath, E.R. Price, C. Takemoto, T. Badalian, and D.E. Fisher MAP kinase links the transcription factor microphthalmia to c-kit signaling in melanocytes Nature 391 1998 298 301
83. K. Nagata, K. Tanaka, K. Ogawa, K. Kemmotsu, T. Imai, and O. Yoshie Selective expression of a novel surface molecule by human Th2 cells in vivo J Immunol 162 1999 1278 1286
84. 2 receptors DP and chemotractant receptor-homologous molecule expressed on Th2 cells/DP2 Clin Exp Allergy 34 2004 1283 1290
85. 2 receptors DP and CRTH2 in human nasal mucosa Prostaglandins Other Lipid Mediat 73 2004 87 101
86. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1999 1193 1226
87. K. Nagata, H. Hirai, K. Tanaka, K. Ogawa, T. Aso, and K. Sugamura CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s) FEBS Lett 459 1999 195 199
88. 2 receptor, CRTH2 Br J Pharmacol 137 2002 1163 1172
89. P.K. Rangachari, P.A. Betti, E.T. Prior, and L.J. Roberts Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? J Pharmacol Exp Ther 275 1995 611 617
90. 2 receptors CRTH2 and DP J Allergy Clin Immunol 108 2001 982 988
91. 2 on helper T cell functions Biochem Biophys Res Commun 316 2004 1009 1014
92. 2 modulates human neutrophil intracellular calcium flux and inhibits superoxide release via its ring carbonyl Life Sci 46 1990 793 801
93. 2 selectively induces chemotaxis in T Helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J Exp Med 193 2001 255 261
94. 2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forbrain Proc Natl Acad Sci USA 91 1994 11998 12002
95. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection J Exp Med 193 2001 1138 1148
96. 2 and reproduction Am J Reprod Immunol 47 2002 295 302
97. 2 Invest Ophthalmol Vis Sci 31 1990 138 146
98. 2 receptor sites in human eyes J Ocular Pharm Ther 20 6 2004 489 508
99. Y. Boie, N. Sawyer, D.M. Slipetz, K.M. Metters, and M. Abramo-Vitz Molecular cloning and characterization of the human prostanoid DP receptor J Biol Chem 270 1995 18910 18916
100. H. Abe, T. Takeshita, K. Nagata, T. Arita, Y. Endo, and T. Fujita Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family Gene 227 1999 71 77
101. 2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells J Immunol 170 2003 4943 4952
102. 2-mediated manner Mol Hum Reprod 8 2002 181 187
103. 2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis J Immunol 170 2003 4752 4758
104. H2 lymphocyte shape change, CD11a/CD18 expression and cytokine production Proceedings of the 12th international conference on advances in prostaglandin, leukotriene and other bioactive lipid research 2002
105. 2) a potent coronary vasoconstrictor agent in the guinea pig isolated heart Naunyn Schmiedebergs Arch Pharmacol 302 1978 61 62
106. H2 lymphocytes Prostaglandins Other Lipid Mediat 75 2005 153 167
107. 2 are potent activators of human eosinophils J Immunol 168 2002 3563 3569
108. E. Böhm, G.J. Sturm, I. Weiglhofer, H. Sandig, M. Shichijo, and A. McNamee 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils J Biol Chem 279 2004 7663 7670
109. 2 receptor, CRTH2 J Immunol 168 2002 981 985
110. A.N. Hata, R. Zent, M.D. Breyer, and R.M. Breyer Expression and molecular pharmacology of the mouse CRTH2 receptor J Pharmacol Exp Ther 306 2003 463 470
111. 2 receptor Biochem Biophys Res Commun 307 2003 797 802
112. 2 receptor DP2/CRTH2 increases allergic inflammation in mouse J Immunol 174 2005 3703 3708
113. 2 in patients with systemic mastocytosis N Engl J Med 303 1980 1400 1404
114. 2 generation after activation of rat and human mast cells with anti-IgE J Immunol 129 1982 1627 1631
115. 2 from human skin in vivo and in vitro during immediate allergic reactions Br J Pharmacol 94 1988 773 780
116. L. Cosmi, F. Annunziato, M.I.G. Galli, R.M.E. Maggi, K. Nagata, and S. Romagnani CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease Eur J Immunol 30 2000 2972 2979
117. 2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor J Pharm Exp Ther 312 2005 954 960
118. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor Blood 98 2001 1942 1948
119. Y. Fujitani, T. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipcalin-type prostaglandin D synthase transgenic mice J Immunol 168 2002 443 449
120. 2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways Eur J Immunol 33 2003 889 898
121. V. Angeli, D. Staumont, A.-S. Charbonnier, H. Hammad, P. Gosset, and M. Pichavant Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses J Immunol 172 2004 3822 3829
122. R.M. Naclerio, H.L. Meier, A. Kagey-Sobotka, N.F. Adkinson, D.A. Meyers, and P.S. Norman Mediator release after nasal airway challenge with allergen Am Rev Respir Dis 128 1983 597 602
123. R.M. Naclerio, D. Proud, A.G. Togias, N.F. Adkinson, D.A. Meyers, and A. Kagey-Sobotka Inflammatory mediators in late antigen-induced rhinitis N Engl J Med 313 1985.65 70
124. A. Arimura, K. Yasui, J. Kishino, F. Asanuma, H. Hasegawa, and S. Kakudo Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751 J Pharmacol Exp Ther 298 2001 411 419
125. 2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine J Exp Med 198 2003 533 543
126. J.A. Gonzalo, Y. Pan, C.M. Lloyd, G.Q. Jia, G. Yu, and B. Dussault Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation J Immunol 163 1999 403 411
127. 2 formed in human plasma Proc Natl Acad Sci USA 81 1984 1317 1321
128. 2, in human urine J Biol Chem 263 1988 16619 16625
129. 2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
130. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 1995 12953 12956
131. 2: the anti-inflammatory prostaglandin? Clinical Immunol 114 2005 100 109
132. 2 and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor γ-independent mechanisms involving reactive oxygenated species J Biol Chem 277 2002 29681 29685
133. 2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway J Immunol 168 2002 1372 1379
134. M.K. Greene, B. Blumberg, O.W. McBride, H.F. Yi, K. Kronquist, and K. Kwan Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expr 4 1995 281 299
135. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, - beta, and -gamma in the adult rat Endocrinology 137 1995 354 366
136. K. Maeyama, M. Emi, and M. Tachibana Nuclear receptors as targets for drug development: peroxisome proliferators-activated receptor γ in mast cells - its role in proliferation and differentiation J Pharmacol Sci 97 2005 190 194
137. T. Lemberger, B. Desvergne, and W. Wahli Peroxisome proliferator- activated receptors: a nuclear receptor signaling pathway in lipid physiology Annu Rev Cell Dev Biol 12 1996 335 363
138. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator activated receptor-γ is a negative regulation of macrophage activation Nature 391 1998 79 82
139. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
140. X. Zhang, M.C. Rodriguez-Galán, J.J. Subleski, J.R. Ortaldo, D.L Hodge, and J.-M. Wang Peroxisome proliferators-activated receptor-γ and its ligands attenuate biologic functions of human natural killer cells Blood 104 2004 3276 3284
141. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro Am J Pathol 153 1998 17 23
142. 2 on tumor necrosis factor-alpha-induced gene expression Arterioscler Thromb Vasc Biol 25 2005 710 716
143. Y. Kawahito, M. Kondo, Y. Tsubouchi, A. Hashiramoto, D. Bishop-Bailey, and K. Inoue 15-Deoxydelta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats J Clin Invest 106 2000 189 197
144. M. Heneka, D. Feinstein, E. Galea, M. Gleichmann, U. Wullner, and T. Klockgether Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granular cells from cytokine induced apoptotic cell death by inhibition of inducible nitric oxide synthase J Neuroimmunol 100 1999 156 168
145. M. Heneka, T. Klockgether, and D. Feinstein Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo J Neurosci 20 2000 6862 6867
146. S. Cuzzocrea, A. Ianaro, N.S. Wayman, E. Mazzon, B. Pisano, and L. Dugo The cyclopentenone prostaglandin 15-deoxy-delta (12,14)-PGJ(2) attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat Br J Pharmacol 138 2003 678 688
147. N.S. Wayman, Y. Hattori, M.C. Mcdonald, H. Mota-Filipe, S. Cuzzocrea, and B. Pisano Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size FASEB J 16 2002 1027 1040
148. S. Cuzzocrea, B. Pisano, L. Dugo, A. Ianaro, N.S.A. Patel, and R. Di Paola Rosiglitazone and 15-deoxy-delta(12,14)-prostaglandin J(2), ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut Br J Pharmacol 140 2003 366 376
149. P.K. Chatterjee, N.S.A. Patel, S. Cuzzocrea, P.A.J. Brown, K.N. Stewart, and H. Mota-Filipe The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- prostaglandin J(2) ameliorates ischemic acute renal failure Cardiovasc Res 61 2004 630 643
150. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists J Neurosci 20 2000 558 567
151. 2 and proliferator activation receptor-γ agonists J Immunol 164 2000 1498 1504
152. K. Yamamoto, R. Ohki, R.T. Lee, U. Ikeda, and K. Shimada Peroxisome proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes Circulation 104 2001 1670 1675
153. S. Hortelano, A. Castrillo, A.M. Alvarez, and L. Boscá Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages J Immunol 165 2000 6525 6531
154. 2 for induction of human articular chondrocyte apoptosis in arthritis J Biol Chem 279 2004 37939 37950
155. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans PPAR-gamma dependent and independent effects on macrophagegene expression in lipid metabolism and inflammation Nat Med 7 2001 48 52
156. 2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of IκBα degradation using a peroxisome proliferator-activated receptor-γ- independent mechanism J Immunol 168 2002 6232 6243
157. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, and M. Karin Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase Nature 403 2000 103 108
158. T. Tsukada, M. Rosenfeld, R. Ross, and A.M. Gown Immunocytochemical analysis of cellular components in lesions of atherosclerosis of the Watanabe and fat-fed rabbit using monoclonal antibodies Arteriosclerosis 6 1986 601 613
159. M. Kaartinen, A. Penttila, and P.T. Kovanen Mast cells of two types differing in neutral protease composition in the human aortic intima: demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas Arterioscler Thromb Vasc Biol 14 1994 966 972
160. 2 synthase expression in vascular endothelial cells Circ Res 86 2000 967 973
161. N. Hirawa, Y. Uehara, M. Yamakado, Y. Toya, T. Gomi, and T. Ikeda Lipocalin-type prostaglandin dsynthase in essential hypertension Hypertension 39 2002 449 454
162. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells Circ Res 82 1998 204 209
163. 2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells J Hypertens 20 2002 1347 1354
164. J. Pfeilschifter, D. Kunz, and H. Muhl Nitric oxide: an inflammatory mediator of glomerular mesangial cells Nephron 64 1993 518 525
165. S. Bachmann, and P. Mundel Nitric oxide in the kidney: synthesis, localization, and function Am J Kidney Dis 24 1994 112 129
166. T. Tetsuka, D. Daphna-Iken, B.W. Miller, Z. Guan, L.D. Baier, and A.R. Morrison Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells J Clin Invest 97 1994 2051 2056
167. 2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion Eur J Immunol 33 2003 2764 2772